Sign In
Buy ATRS
$5.59
+0 (+0%)
At Close: Jul 20, 2022
Antares Pharma to Present at the Raymond James Human Health Innovations Conference
08:30am, Tuesday, 15'th Jun 2021
EWING, N.J., June 15, 2021 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a specialty pharmaceutical company, today announced that Robert F. Apple, President and Chief Ex
Antares Pharma to Present at the Jefferies Virtual Healthcare Conference
08:30am, Wednesday, 26'th May 2021
EWING, N.J., May 26, 2021 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a specialty pharmaceutical company, today announced that Robert F. Apple, President and Chief Exe
Antares Pharma, Inc. (ATRS) CEO Robert Apple on Q1 2021 Results - Earnings Call Transcript
06:19pm, Thursday, 06'th May 2021
Antares Pharma, Inc. (ATRS) CEO Robert Apple on Q1 2021 Results - Earnings Call Transcript
Antares Pharma (ATRS) Meets Q1 Earnings Estimates
10:31am, Thursday, 06'th May 2021
Antares Pharma (ATRS) delivered earnings and revenue surprises of 0.00% and 2.98%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Antares Pharma Appoints Joseph Renda as Senior Vice President of Commercial
07:15am, Thursday, 06'th May 2021
EWING, N.J., May 06, 2021 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a specialty pharmaceutical company, today announced the appointment of Joseph V. Renda as Senior
Antares Pharma Announces Poster Presentation at the Pediatric Endocrine Society 2021 Virtual Annual Meeting
08:30am, Monday, 03'rd May 2021
EWING, N.J., May 03, 2021 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a specialty pharmaceutical company, today announced that data highlighting the therapeutic potent
Antares Pharma to Report First Quarter 2021 Financial and Operating Results
08:30am, Tuesday, 27'th Apr 2021
EWING, N.J., April 27, 2021 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a specialty pharmaceutical company, today announced it will release its first quarter 2021 fina
Antares Pharma - Why It's A $4 Stock (And Might Remain So)
06:40pm, Monday, 26'th Apr 2021
Antares Pharma operates in crowded markets with relatively low barriers to entry and intense competition. Their flagship product, XYOSTED, grew significantly in 2019 and 2020 but competitors may enter
Antares Pharma Appoints Dr. Peter Richardson as Executive Vice President, Research and Development and Chief Medical Officer
08:30am, Monday, 26'th Apr 2021
EWING, N.J., April 26, 2021 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a specialty pharmaceutical company, today announced the appointment of Peter Richardson, MRCP,
A Trio of Stock Picks for the Value Investor
01:02pm, Sunday, 11'th Apr 2021
In my opinion, choosing U.S.-listed securities that have the following characteristics represents a solid starting point when looking for potential value opportunities:
Antares Pharma's (ATRS) CEO Bob Apple on Q4 2020 Results - Earnings Call Transcript
12:20pm, Tuesday, 02'nd Mar 2021
Antares Pharma's (ATRS) CEO Bob Apple on Q4 2020 Results - Earnings Call Transcript
Antares Pharma (ATRS) Q4 Earnings Lag Estimates
09:05am, Tuesday, 02'nd Mar 2021
Antares Pharma (ATRS) delivered earnings and revenue surprises of -25.00% and 7.99%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Recap: Antares Pharma Q4 Earnings
07:22am, Tuesday, 02'nd Mar 2021
Shares of Antares Pharma (NASDAQ:ATRS) were unchanged after the company reported Q4 results. Quarterly Results Earnings per share were flat 0.00% over the past year to $0.03, which were in line with t
Antares Pharma to Present at Two Upcoming Investor Conferences
04:30pm, Wednesday, 24'th Feb 2021
EWING, N.J., Feb. 24, 2021 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a pharmaceutical technology company, today announced that Robert F. Apple, President and Chief E
Antares Pharma to Report Fourth Quarter and Full-Year 2020 Financial and Operating Results
08:30am, Tuesday, 23'rd Feb 2021
EWING, N.J., Feb. 23, 2021 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a pharmaceutical technology company, today announced it will release its fourth quarter and full
